The University of Lisbon (ULisboa; Portuguese: Universidade de Lisboa, pronounced: [univɨɾsiˈdad(ɨ) dɨ liʒˈboɐ]) is a public research university in Lisbon, and the largest university in Portugal.
It was founded in 2013, from the merger of two previous public universities located in Lisbon, the former University of Lisbon (1911–2013) and the Technical University of Lisbon (1930–2013). The history of a university in Lisbon dates back to the 13th century.
The Latest Updated Research News:
University of Lisbon research articles from Innovation Toronto
Ground-breaking research has successfully created the world’s first truly electronic textile, using the wonder material Graphene
An international team of scientists, including Professor Monica Craciun from the University of Exeter, have pioneered a new technique to embed transparent, flexible graphene electrodes into fibres commonly associated with the textile industry.
The discovery could revolutionise the creation of wearable electronic devices, such as clothing containing computers, phones and MP3 players, which are lightweight, durable and easily transportable.
The international collaborative research, which includes experts from the Centre for Graphene Science at the University of Exeter, the Institute for Systems Engineering and Computers, Microsystems and Nanotechnology (INESC-MN) in Lisbon, the Universities of Lisbon and Aveiro in Portugal and the Belgian Textile Research Centre (CenTexBel), is published in the leading scientific journal Scientific Reports.
Professor Craciun, co-author of the research said: “This is a pivotal point in the future of wearable electronic devices. The potential has been there for a number of years, and transparent and flexible electrodes are already widely used in plastics and glass, for example. But this is the first example of a textile electrode being truly embedded in a yarn. The possibilities for its use are endless, including textile GPS systems, to biomedical monitoring, personal security or even communication tools for those who are sensory impaired. The only limits are really within our own imagination.”
At just one atom thick, graphene is the thinnest substance capable of conducting electricity. It is very flexible and is one of the strongest known materials. The race has been on for scientists and engineers to adapt graphene for the use in wearable electronic devices in recent years.
This new research has identified that ‘monolayer graphene’, which has exceptional electrical, mechanical and optical properties, make it a highly attractive proposition as a transparent electrode for applications in wearable electronics. In this work graphene was created by a growth method called chemical vapour deposition (CVD) onto copper foil, using a state-of-the-art nanoCVD system recently developed by Moorfield.
The collaborative team established a technique to transfer graphene from the copper foils to a polypropylene fibre already commonly used in the textile industry.
Dr Helena Alves who led the research team from INESC-MN and the University of Aveiro said: “The concept of wearable technology is emerging, but so far having fully textile-embedded transparent and flexible technology is currently non-existing. Therefore, the development of processes and engineering for the integration of graphene in textiles would give rise to a new universe of commercial applications. “
Dr Ana Neves, Associate Research Fellow in Prof Craciun’s team from Exeter’s Engineering Department and former postdoctoral researcher at INESC added: “We are surrounded by fabrics, the carpet floors in our homes or offices, the seats in our cars, and obviously all our garments and clothing accessories. The incorporation of electronic devices on fabrics would certainly be a game-changer in modern technology.
“All electronic devices need wiring, so the first issue to be address in this strategy is the development of conducting textile fibres while keeping the same aspect, comfort and lightness. The methodology that we have developed to prepare transparent and conductive textile fibres by coating them with graphene will now open way to the integration of electronic devices on these textile fibres.”
Dr Isabel De Schrijver,an expert of smart textiles fromCenTexBel said: “Successful manufacturing of wearable electronics has the potential for a disruptive technology with a wide array of potential new applications. We are very excited about the potential of this breakthrough and look forward to seeing where it can take the electronics industry in the future.”
Professor Saverio Russo, co-author and also from the University of Exeter, added: “This breakthrough will also nurture the birth of novel and transformative research directions benefitting a wide range of sectors ranging from defence to health care. “
“Inhibiting DGKi seems to reverse the effects of cystic fibrosis”
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Regensburg University, both in Germany, and the University of Lisboa, in Portugal, have discovered a promising potential drug target for cystic fibrosis. Their work, published online today in Cell, also uncovers a large set of genes not previously linked to the disease, demonstrating how a new screening technique can help identify new drug targets.
Cystic fibrosis is a hereditary disease caused by mutations in a single gene called CFTR. These mutations cause problems in various organs, most notably making the lining of the lungs secrete unusually thick mucus. This leads to recurrent life-threatening lung infections, which make it increasingly hard for patients to breathe. The disease is estimated to affect 1 in every 2500-6000 newborns in Europe.
In patients with cystic fibrosis, the mutations to CFTR render it unable to carry out its normal tasks. Among other things, this means CFTR loses the ability to control a protein called the epithelial sodium channel (ENaC). Released from CFTR’s control, ENaC becomes hyperactive, cells in the lungs absorb too much sodium and – as water follows the sodium – the mucus in patients’ airways becomes thicker and the lining of the lungs becomes dehydrated. The only drug currently available that directly counteracts a cystic fibrosis-related mutation only works on the three percent of patients that carry one specific mutation out of the almost 2000 CFTR mutations scientists have found so far.
Thus, if you were looking for a more efficient way to fight cystic fibrosis, finding a therapy that would act upon ENaC instead of trying to correct that multitude of CFTR mutations would seem like a good option. But unfortunately, the drugs that inhibit ENaC, mostly developed to treat hypertension, don’t transfer well to cystic fibrosis, where their effects don’t last very long. So scientists at EMBL, Regensburg University and University of Lisboa set out to find alternatives.
“In our screen, we attempted to mimic a drug treatment,” says Rainer Pepperkok, whose team at EMBL developed the technique, “we’d knock down a gene and see if ENaC became inhibited.”
Starting with a list of around 7000 genes, the scientists systematically silenced each one, using a combination of genetics and automated microscopy, and analysed how this affected ENaC. They found over 700 genes which, when inhibited, brought down ENaC activity, including a number of genes no-one knew were involved in the process. Among their findings was a gene called DGKi. When they tested chemicals that inhibit DGKi in lung cells from cystic fibrosis patients, the scientists discovered that it appears to be a very promising drug target.
“Inhibiting DGKi seems to reverse the effects of cystic fibrosis, but not block ENaC completely,” says Margarida Amaral from the University of Lisboa, “indeed, inhibiting DGKi reduces ENaC activity enough for cells to go back to normal, but not so much that they cause other problems, like pulmonary oedema.”